Abionyx

Developer of therapeutics for treating rare diseases and severe inflammatory conditions

placeBalma, Occitanie, France calendar_todayFounded 2005 groups63 employees language abionyx.com

Registered entities

Social engagement

Social engagement: 2.1K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include Orbimed, EDF Ventures, Sofinnova Partners, Healthcap.

Investor typeCountShare
Venture capital545%
Private equity327%
Bank & private debt19%
Other / undisclosed218%

Recent activity

21 Nov 2025
Partnership
SEBIA
Coming soon